The advent of cutting-edge genomic technologies has dramatically revolutionized modern clinical genetics, enabling comprehensive insights into contemporary disease states with unprecedented resolution. However, these technologies have predominantly been applied to fresh or recently collected genetic material, leaving a vast reservoir of older clinical specimens largely untapped. This limitation curtails our ability to dissect the historical genomic landscape of diseases and understand how genetic factors influencing disease susceptibility have evolved over extended periods.

Harnessing a novel approach inspired by methodologies pioneered in the field of ancient DNA research, scientists at the University of Chicago have adapted sophisticated techniques to robustly recover and sequence degraded DNA from formalin-fixed, paraffin-embedded (FFPE) medical samples dating back nearly a century. This approach bridges the gap between molecular archaeology and modern medical genomics, enabling exploration of genetic changes in tumor biology across decades.

The research was unveiled in a forthcoming presentation at the prestigious Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo in Boston, a gathering of leading molecular diagnostic experts aimed at pushing the boundaries of disease understanding through genomic science. The team meticulously selected colorectal cancer samples spanning an extraordinary temporal range—from 1932 to 2023—to investigate evolving genetic landscapes and microbial constituents within tumor microenvironments.

Colorectal cancer’s increasing incidence among younger adults, a demographic historically at lower risk, poses a perplexing epidemiological enigma. Contemporary statistics reveal a troubling trend: a 35-year-old today faces twice the likelihood of developing colorectal cancer compared to their counterpart in 1985. A comprehensive temporal genomic analysis promised to shed light on potential genetic drivers underpinning this shift.

Retrieval of actionable genetic material from the FFPE specimens required precise optimization of DNA extraction techniques. The research team innovatively fine-tuned steps for meticulous removal of paraffin wax and chemical preservatives—agents known to complicate nucleic acid recovery. Their tailored protocols maximized yield of usable DNA fragments, a critical and delicate step given the high degree of DNA fragmentation typical of archival tissue samples.

To reconstruct meaningful genomic data from these fragmented strands, the researchers employed a bespoke bioinformatics pipeline rooted in digital tools originally designed to handle ancient DNA. These tools adeptly aligned damaged and incomplete sequences with the human reference genome, overcoming challenges associated with post-mortem DNA damage such as cytosine deamination and strand breaks, allowing for accurate genetic variant calling in an otherwise challenging data landscape.

The pipeline incorporated whole-genome sequencing complemented by a targeted gene-enrichment strategy focusing on a panel of oncogenes and tumor suppressor genes relevant to colorectal cancer (using the OncoPlus panel). Crucially, protocols were modified to preserve ultra-short DNA fragments, which are traditionally discarded during library preparation, ensuring the recovery of maximum genomic information from severely degraded samples.

Beyond human genomic data, the team probed the metagenomic component embedded within the tumor tissues. Analysis of non-human DNA sequences revealed presence not only of commensal gut microbiota but also specific bacterial species previously implicated in colorectal carcinogenesis. This innovative inclusion reveals the multifaceted nature of tumor microenvironments, where microbial constituents may influence oncogenic processes and disease progression.

Dr. Alexander Guzzetta, M.D., Ph.D., leading the initiative alongside ancient DNA expert Maanasa Raghavan, Ph.D., remarked on the groundbreaking nature of this dual genomic and microbial analysis. He emphasized the significance of detecting cancer-associated bacterial species retrospectively across decades, a window that could elucidate shifts in tumor microbiomes and their potential role in the epidemiological transition of colorectal cancer.

The implications of this research extend far beyond colorectal cancer. The demonstrated capacity to recover and decipher genetic information from long-preserved clinical samples paves the way for retrospective analyses of numerous diseases. Guzzetta envisions a future where molecular historians of medicine can unravel the genomic evolution of infectious pathogens, inherited disorders, and cancer types with temporal depth previously unattainable.

Fundamentally, this methodology offers an unprecedented tool for molecular epidemiology and evolutionary pathology, bridging the gap between historic medical archives and cutting-edge genomic science. The ability to track genetic mutation patterns, microbial interactions, and disease susceptibility shifts longitudinally could revolutionize disease prevention, diagnosis, and treatment paradigms.

The team’s work will be highlighted in both a platform presentation and poster session at the AMP 2025 event, scheduled for November 13 at the Thomas M. Menino Convention and Exhibition Center in Boston. Guzzetta will be available to engage with the scientific community and media to discuss the technical intricacies and transformative potential of this research.

As attention turns increasingly to the dynamic interplay between human genetics, microbiomes, and disease, this pioneering approach heralds a new era where historical genetic data fragments, once lost to time, become key to unlocking medical mysteries of the past, present, and future.

Subject of Research:
Advancements in sequencing degraded genetic material from archival medical samples to study disease evolution, with a focus on colorectal cancer genetics and tumor microbiomes.

Article Title:
Decoding Nearly a Century of Cancer Genomics: Ancient DNA Techniques Revitalize Colorectal Tumor Analysis

News Publication Date:
2025 (Ahead of AMP 2025 Annual Meeting & Expo)

Web References:
Association for Molecular Pathology 2025 Annual Meeting & Expo

Keywords:
Pathology, Disease susceptibility, Ancient DNA, DNA damage, DNA, Genetic material, Genetic analysis, Colorectal cancer, Colon cancer

Schistosomiasis remains a persistent public health challenge, particularly across sub-Saharan Africa, where freshwater snails of the genus Biomphalaria serve as essential intermediate hosts for the schistosome parasites. These parasites complete part of their complex life cycle within the snails before infecting humans, causing chronic illness marked by liver damage, bladder dysfunction, and impaired growth in children. The control of schistosomiasis traditionally hinges on mass drug administration targeting human populations, but interruption of disease transmission via the snail hosts has long been recognized as a crucial but elusive goal.

The recent study, published in Nature Communications, involved a multidisciplinary team employing cutting-edge genomic tools to probe the genetic architecture of Biomphalaria populations sourced across endemic regions in Africa. By sequencing the genomes of hundreds of individual snails with known susceptibility or resistance phenotypes, the researchers performed a high-resolution GWAS to pinpoint genomic loci consistently associated with resistance to schistosome infection. Their analyses identified multiple candidate genes implicated in immune modulation and epithelial barrier functions.

One of the most striking revelations of the study is the identification of several loci harboring genes involved in the snail’s innate immune response, particularly those encoding pattern recognition receptors and signaling molecules pivotal for pathogen detection. These genetic variants appear to empower resistant snails with an enhanced ability to recognize and mount robust defenses against invading schistosome larvae. The elucidation of these pathways provides a mechanistic explanation for observed differences in infection outcomes and marks a significant departure from previous empirical but unexplained associations.

Moreover, the researchers uncovered variants linked to genes governing the snail’s epithelial integrity, suggesting that physical barriers in the snail’s tissue play a complementary role in resistance. Strengthened barrier functions may prevent the parasite from successfully penetrating or establishing infection, adding a vital layer to the host defense strategy. Such dual insights into both immune and structural components highlight the multifaceted nature of resistance and the evolutionary arms race shaping host-parasite dynamics.

The study further revealed that these resistance-associated genetic markers are unevenly distributed among natural snail populations, with certain geographical isolates harboring more advantageous alleles. This population genomic perspective is crucial for understanding the epidemiology of schistosomiasis and provides a valuable framework for targeted interventions. By mapping the distribution of resistant genotypes, public health programs may optimize biological control strategies tailored to local snail populations.

Importantly, the findings carry substantial implications for the development of novel control methods that transcend traditional chemical molluscicides, which often suffer from environmental toxicity and the evolution of resistance. Genetic insights pave the way for innovative approaches such as the selective breeding or genetic engineering of snails with enhanced schistosome resistance, thereby disrupting the parasite life cycle at its aquatic stage. Such environmentally sustainable strategies could significantly reduce disease transmission at scale.

The researchers also emphasize the potential for leveraging these genetic markers as molecular tools to monitor snail populations in the field. Rapid genetic assays can detect the presence and frequency of resistance alleles, enabling real-time surveillance and adaptive management of schistosomiasis hotspots. This intersection of genomics and epidemiology embodies the promise of precision public health in tackling entrenched infectious diseases.

Beyond immediate applications, the study enriches our fundamental understanding of invertebrate immunity and evolutionary biology. Unlike vertebrates, mollusks lack adaptive immunity, relying solely on innate mechanisms, yet they exhibit remarkable specificity and memory-like responses. Decoding the genetic basis of these phenomena illuminates the complexity of host defense and may inform broader research into innate immune systems across taxa.

Collaborations across genomics, parasitology, ecology, and public health were essential to surmount the challenges inherent in studying wild snail populations, whose genetic diversity and environmental variability confound simplistic analyses. The integration of high-throughput sequencing technologies with field ecology and controlled infection experiments exemplifies the increasingly interdisciplinary nature of modern infectious disease research.

While the landscape of schistosomiasis control is poised for transformation, the authors caution that translating genetic insights into practical interventions will require sustained investment and ethical deliberations, particularly regarding the release of modified organisms into natural ecosystems. The social, ecological, and evolutionary repercussions of such interventions demand careful risk assessment and community engagement.

Nevertheless, this landmark study marks a pivotal shift in the global battle against schistosomiasis, offering a tangible genetic foothold to undermine the parasite’s aquatic reservoirs. As the world continues to grapple with the burden of neglected tropical diseases, harnessing the power of genomics to disrupt transmission cycles holds unparalleled promise.

Looking ahead, the research team advocates for continued exploration into the functional characterization of identified genes, including experimental validation of their roles in resistance mechanisms. Advances in CRISPR gene editing and snail transgenesis provide tools to interrogate these candidate genes with unprecedented precision. Additionally, expanding genomic surveys to include other snail species and parasite strains will deepen insights into co-evolutionary processes.

The integration of these genomic discoveries with ecological modeling and climate change projections could further refine predictions of schistosomiasis risk landscapes. Environmental changes influence snail habitats and population dynamics, factors intimately linked to disease propagation. Thus, a holistic approach combining genetics, environment, and epidemiology is essential to outpace schistosome transmission in an era of rapid global change.

Ultimately, this pioneering work underscores the transformative potential of genomic science to address one of humanity’s oldest scourges through innovative, sustainable, and targeted measures. By illuminating the genetic defenses that snails wield against schistosome invaders, it charts a bold new course for epidemiologists, public health officials, and molecular biologists united in the quest to consign schistosomiasis to history.

Subject of Research: Genetic basis of schistosome resistance in African snail vectors (Biomphalaria species)

Article Title: Genes linked to schistosome resistance identified in a genome-wide association study of African snail vectors

Article References:
Pennance, T., Tennessen, J.A., Spaan, J.M. et al. Genes linked to schistosome resistance identified in a genome-wide association study of African snail vectors. Nat Commun 16, 6918 (2025). https://doi.org/10.1038/s41467-025-61760-8

Image Credits: AI Generated